FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Asterios Karagiannis

Research Profile

Chemicals & Drugs

Disorders

Concepts & Ideas

Co-author Network

Publications

TOP 3
Niki Katsiki; Vasilios G Athyros; Asterios Karagiannis; Dimitri P Mikhailidis
Hyperuricaemia: more than just a cause of gout?
Panagiotis Anagnostis; Vasilios G Athyros; Marina Kita; Asterios Karagiannis
Is there any association between adiponectin gene polymorphisms and cardiovascular disease?
Vasilios G Athyros; Niki Katsiki; Asterios Karagiannis
Prevalence and clinical outcome of polyvascular atherosclerotic disease in patients undergoing coronary intervention.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Asterios Karagiannis (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Niki Katsiki; Vasilios G Athyros; Asterios Karagiannis; Dimitri P Mikhailidis
Hyperuricaemia: more than just a cause of gout?
Journal of cardiovascular medicine (Hagerstown, Md.) 2013;14(6):397-402.
2013: Panagiotis Anagnostis; Vasilios G Athyros; Marina Kita; Asterios Karagiannis
Is there any association between adiponectin gene polymorphisms and cardiovascular disease?
Angiology 2013;64(4):253-6.
2013: Vasilios G Athyros; Niki Katsiki; Asterios Karagiannis
Prevalence and clinical outcome of polyvascular atherosclerotic disease in patients undergoing coronary intervention.
Circulation journal : official journal of the Japanese Circulation Society 2013;77(5):1348.
2013: N Katsiki; Asterios Karagiannis; Dimitri P Mikhailidis
Diabetes, bilirubin and amputations: is there a link?
Diabetologia 2013;56(4):683-5.
2013: Efstathios D Pagourelias; Paraskevi Zorou; Georgios Giannoglou; Asterios Karagiannis; Evangelia Kouidi; Vasilis G Athyros; Asterios Deligiannis; Georgios K Efthimiadis; Paraschos Geleris
Efficacy of various "classic" echocardiographic and laboratory indices in distinguishing the "gray zone" between athlete's heart and hypertrophic cardiomyopathy: a pilot study.
Echocardiography (Mount Kisco, N.Y.) 2013;30(2):131-9.
2013: Konstantinos Tziomalos; Asterios Karagiannis; Dimitri P Mikhailidis; Vasilios G Athyros
Colesevelam: a new and improved bile Acid sequestrant?
Current pharmaceutical design 2013;19(17):3115-23.
2013: Niki Katsiki; Vasilios G Athyros; Asterios Karagiannis; Eleni Theocharidou; Dimitri P Mikhailidis
Ezetimibe therapy for dyslipidemia: an update.
Current pharmaceutical design 2013;19(17):3107-14.
2013: Vasilios G Athyros; Asterios Karagiannis; Niki Katsiki; Dimitri P Mikhailidis
Comment to "atorvastatin improves disease activity of nonalcoholic steatohepatitis partly through its tumour necrosis factor-α-lowering property".
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2013;45(1):82-3.
2013: Panagiotis Anagnostis; Vasilios G Athyros; Asterios Karagiannis; Niki Katsiki; Marina Kita; Fotini Adamidou; Dimitri P Mikhailidis
11beta-Hydroxysteroid dehydrogenase type 1 inhibitors: novel agents for the treatment of metabolic syndrome and obesity-related disorders?
Metabolism: clinical and experimental 2013;62(1):21-33.
2012: Niki Katsiki; Dimitri P Mikhailidis; Vasilios G Athyros; Asterios Karagiannis
Editorial: aliskiren/amlodipine single-pill combinations: more evidence in favour of combination formulations for the treatment of hypertension.
Current vascular pharmacology 2012;10(6):745-7.
2012: Vasilios G Athyros; Asterios Karagiannis; Niki Katsiki; Dimitri P Mikhailidis
Relation of improvement in glomerular filtration rate with atorvastatin to reductions in heart failure morbidity.
The American journal of cardiology 2012;110(5):763.
2012: Niki Katsiki; Vasilios G Athyros; Asterios Karagiannis; Dimitri P Mikhailidis
Smoking and non-alcoholic steatohepatitis (NASH): the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) trial.
Journal of hepatology 2012;57(2):476.
2012: Vassilios G Athyros; Eleni Bilianou; Moses S Elisaf; Emmanuel S Ganotakis; Asterios Karagiannis; Evangelos N Liberopoulos; Dimitri P Mikhailidis; Konstantinos Tziomalos; Apostolos Achimastos; Theodore Alexandrides
Long-term impact of multifactorial treatment on new-onset diabetes and related cardiovascular events in metabolic syndrome: a post hoc ATTEMPT analysis.
Angiology 2012;63(5):358-66.
2012: Charalambos Koumaras; Dimitri P Mikhailidis; Eirini Stavrinou; Maria Tzimou; Vasilios G Athyros; Thomas D Gossios; Theodora Griva; Niki Katsiki; Asterios Karagiannis
Role of antihypertensive drugs in arterial 'de-stiffening' and central pulsatile hemodynamics.
American journal of cardiovascular drugs : drugs, devices, and other interventions 2012;12(3):143-56.
2012: Vasilios G Athyros; Asterios Karagiannis; Niki Katsiki; Dimitri P Mikhailidis
Statins in patients with renal dysfunction.
The American journal of cardiology 2012;109(10):1537.
2012: Vasilios G Athyros; Asterios Karagiannis; Niki Katsiki; Dimitri P Mikhailidis
Editorial: should chronic kidney disease be considered as a coronary heart disease equivalent?
Current vascular pharmacology 2012;10(3):374-7.
2012: Vasilios G Athyros; Asterios Karagiannis; Niki Katsiki; Dimitri P Mikhailidis
Response to 'Mildly decreased glomerular filtration rate is associated with poor coronary heart disease outcome'.
Clinical cardiology 2012;35(5):315; author reply 316-7.
2012: Vasilios G Athyros; Asterios Karagiannis; Niki Katsiki; Dimitri P Mikhailidis
Should raising high-density lipoprotein cholesterol be a matter of debate?
Journal of cardiovascular medicine (Hagerstown, Md.) 2012;13(4):254-9.
2012: Michael S Kostapanos; Vasilios G Athyros; Asterios Karagiannis; Dimitri P Mikhailidis
Mechanisms linking nonalcoholic fatty liver disease with coronary artery disease.
Digestive diseases and sciences 2012;57(4):1109.
2012: Michael S Kostapano; Vasilios G Athyros; Asterios Karagiannis; Niki Katsiki; Dimitri P Mikhailidis
Effects of Losartan vs. Enalapril on the Markers of Metabolic Syndrome.
Oman medical journal 2012;27(2):177.
2012: Vasilios G Athyros; Asterios Karagiannis; Niki Katsiki; Dimitri P Mikhailidis
Stage of chronic kidney disease and severity of coronary heart disease manifestation.
Expert opinion on pharmacotherapy 2012;13(4):457-60.
2012: Michael S Kostapanos; Vasilios G Athyros; Asterios Karagiannis; Dimitri P Mikhailidis
Therapeutic options for statin-intolerant patients.
Current medical research and opinion 2012;28(3):345-9.
2012: Konstantinos Tziomalos; Vassilios G Athyros; Asterios Karagiannis
Non-alcoholic fatty liver disease in type 2 diabetes: pathogenesis and treatment options.
Current vascular pharmacology 2012;10(2):162-72.
2012: Vasilios G Athyros; Thomas D Gossios; Asterios Karagiannis; Niki Katsiki; Dimitri P Mikhailidis
The clinical benefit of implementing guidelines in cardiovascular disease prevention in real world settings.
Archives of medical science : AMS 2012;8(1):6-10.
2012: Niki Katsiki; Vasilios G Athyros; Asterios Karagiannis; Dimitri P Mikhailidis
Managing the combination of non-alcoholic fatty liver disease and metabolic syndrome.
Expert opinion on pharmacotherapy 2012;13(2):287-8; author reply 289-90.
2012: Eydoxia K Mitsiou; Vasilios G Athyros; Asterios Karagiannis; Dimitri I Mikhailidis
Is there a role for hypolipidaemic drug therapy in the prevention or treatment of microvascular complications of diabetes?
The open cardiovascular medicine journal 2012;6():28-32.
2012: Niki Katsiki; Vasilios G Athyros; Asterios Karagiannis; Dimitri P Mikhailidis
Fibrinogen, hematocrit, and platelets in mild kidney dysfunction and the role of uric acid: an Italian male population study.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2012;18(1):113-4.
2012: Niki Katsiki; Vasilios G Athyros; Asterios Karagiannis; Dimitri P Mikhailidis
Efficacy and tolerability of once-weekly rosuvastatin in patients with previous statin intolerance.
Journal of clinical lipidology 2012;6(1):93.
2012: Niki Katsiki; Charalambos Koumaras; Vasilios G Athyros; Asterios Karagiannis
Thinking beyond traditional cardiovascular risk factors: the role of arterial stiffness in targeting residual risk.
Angiology 2012;63(1):9-11.
2012: Konstantinos Tziomalos; Vasilios G Athyros; Asterios Karagiannis; Dimitri P Mikhailidis
Lipid lowering agents and the endothelium: an update after 4 years.
Current vascular pharmacology 2012;10(1):33-41.
2011: Vasilios G Athyros; Matilda Florentin; Thomas D Gossios; Asterios Karagiannis; Konstantinos Tziomalos; Dimitri P Mikhailidis
Is there an additional benefit from coronary revascularization in diabetic patients with acute coronary syndromes or stable angina who are already on optimal medical treatment?
Archives of medical science : AMS 2011;7(6):1067-75.
2011: Vasilios G Athyros; Thomas D Gossios; Apostolos I Hatzitolios; Anna Kakafika; Asterios Karagiannis; Niki Katsiki; Dimitri P Mikhailidis; Aikaterini Papagianni; Christos Savopoulos; Konstantinos Tziomalos
IMproving the imPlemEntation of cuRrent guidelines for the mAnagement of major coronary hearT disease rIsk factors by multifactorial interVEntion. The IMPERATIVE renal analysis.
Archives of medical science : AMS 2011;7(6):984-92.
2011: Vassilios G Athyros; Eleni Bilianou; Moses S Elisaf; Emmanuel S Ganotakis; Anna I Kakafika; Asterios Karagiannis; Genovefa D Kolovou; Evangelos N Liberopoulos; Dimitri P Mikhailidis; Vassilios Nicolaou; Konstantinos Paletas; Dimitrios Petridis; Konstantinos Tziomalos; Apostolos Achimastos; Theodore Alexandrides
Assessing the treatment effect in metabolic syndrome without perceptible diabetes (ATTEMPT): a prospective-randomized study in middle aged men and women.
Current vascular pharmacology 2011;9(6):647-57.
2011: Niki Katsiki; Vasilios G Athyros; Asterios Karagiannis; Dimitri P Mikhailidis
Hyperuricaemia and non-alcoholic fatty liver disease (NAFLD): a relationship with implications for vascular risk?
Current vascular pharmacology 2011;9(6):698-705.
2011: Vassilios G Athyros; Moses Elisaf; Emmanouel S Ganotakis; Olga Giouleme; Asterios Karagiannis; Evangelos N Liberopoulos; Eleni Theocharidou; Konstantinos Tziomalos; Themistoklis Vassiliadis; Dimitri P Mikhailidis
Safety and impact on cardiovascular events of long-term multifactorial treatment in patients with metabolic syndrome and abnormal liver function tests: a post hoc analysis of the randomised ATTEMPT study.
Archives of medical science : AMS 2011;7(5):796-805.
2011: Niki Katsiki; Vasilios G Athyros; Asterios Karagiannis; Dimitri P Mikhailidis
Current treatment for nonalcoholic fatty liver disease.
Expert opinion on pharmacotherapy 2011;12(13):2141-2; author reply 2142.
2011: N Katsiki; Vasilios G Athyros; Asterios Karagiannis; Dimitri P Mikhailidis
Vitamin D deficiency, statin-related myopathy and other links with vascular risk.
Current medical research and opinion 2011;27(9):1691-2.
2011: Efstathios D Pagourelias; Miltiadis Tsaligopoulos; Paraskevi G Zorou; Vasilis G Athyros; Asterios Karagiannis; Georgios K Efthimiadis
Carbon dioxide balneotherapy and cardiovascular disease.
International journal of biometeorology 2011;55(5):657-63.
2011: Vassilios G Athyros; George Bacharoudis; Emmanuel S Ganotakis; Asterios Karagiannis; Evangelos N Liberopoulos; Dimitri P Mikhailidis; Vassilios Nicolaou; Konstantinos Paletas; Konstantinos Tziomalos; Theodore Alexandrides
Association between the changes in renal function and serum uric acid levels during multifactorial intervention and clinical outcome in patients with metabolic syndrome. A post hoc analysis of the ATTEMPT study.
Current medical research and opinion 2011;27(8):1659-68.
2011: Vasilios G Athyros; Asterios Karagiannis; Konstantinos Tziomalos; Dimitri P Mikhailidis
Cardiovascular benefits of bariatric surgery in morbidly obese patients.
Obesity reviews : an official journal of the International Association for the Study of Obesity 2011;12(7):515-24.
2011: Eirini Stavrinou; Konstantinos Tziomalos; Vasilios G Athyros; Thomas D Gossios; Charalambos Koumaras; Asterios Karagiannis
Atherosclerotic renal artery stenosis: an update on diagnosis and management.
Current vascular pharmacology 2011;9(4):465-70.
2011: Panagiotis Anagnostis; Vasilios G Athyros; Asterios Karagiannis; Dimitri P Mikhailidis
Impact of statins on glucose metabolism--a matter of debate.
The American journal of cardiology 2011;107(12):1866.
2011: P Anagnostis; D Selalmatzidou; S A Polyzos; A Panagiotou; A Slavakis; A Panagiotidou; Vasilios G Athyros; Asterios Karagiannis; Dimitri P Mikhailidis; M Kita
Comparative effects of rosuvastatin and atorvastatin on glucose metabolism and adipokine levels in non-diabetic patients with dyslipidaemia: a prospective randomised open-label study.
International journal of clinical practice 2011;65(6):679-83.
2011: Efstathios D Pagourelias; Thomas D Gossios; Konstantinos Tziomalos; Asterios Karagiannis; Paraschos Geleris; Vasilios G Athyros
Residual cardiac risk reduction beyond lipid lowering.
Hellenic journal of cardiology : HJC = Hellēnikē kardiologikē epitheōrēsē 2011;52(3):197-203.
2011: Vasilios G Athyros; Konstantinos Tziomalos; Georgios N Daskalopoulos; Asterios Karagiannis; Dimitri P Mikhailidis
Statin-based treatment for cardiovascular risk and non-alcoholic fatty liver disease. Killing two birds with one stone?
Annals of medicine 2011;43(3):167-71.
2011: Georgios N Daskalopoulos; Artemis Karkanaki; Asterios Karagiannis; Dimitri P Mikhailidis; Vasilios G Athyros
Is the risk for cardiovascular disease increased in all phenotypes of the polycystic ovary syndrome?
Angiology 2011;62(4):285-90.
2011: P Anagnostis; Vasilios G Athyros; F Adamidou; A Panagiotou; M Kita; Asterios Karagiannis; Dimitri P Mikhailidis
Glucagon-like peptide-1-based therapies and cardiovascular disease: looking beyond glycaemic control.
Diabetes, obesity & metabolism 2011;13(4):302-12.
2011: Panagiotis Anagnostis; Vasilios G Athyros; Themistoklis Vasiliadis; Theodora Griva; Kalliopi Patsiaoura; Asterios Karagiannis
Should we consider Addison's disease in the differential diagnosis of persistent hypertransaminasemia? A case report.
Acta gastro-enterologica Belgica 2011;74(1):95-6.
2011: Asterios Karagiannis
Treatment of primary aldosteronism: Where are we now?
Reviews in endocrine & metabolic disorders 2011;12(1):15-20.
2011: Niki Katsiki; Vasilis G Athyros; Asterios Karagiannis; Dimitri P Mikhailidis
Ezetimibe and low density lipoprotein subfractions: an ongoing debate.
Current medical research and opinion 2011;27(3):693-5.
2011: Konstantinos Tziomalos; Vasilios G Athyros; Asterios Karagiannis; Dimitri P Mikhailidis
Dyslipidemia induced by drugs used for the prevention and treatment of vascular diseases.
The open cardiovascular medicine journal 2011;5():85-9.
2011: Niki Katsiki; Dimitri P Mikhailidis; Vasilios G Athyros; Asterios Karagiannis
Alanine aminotransferase is associated with metabolic syndrome independently of insulin resistance.
Circulation journal : official journal of the Japanese Circulation Society 2011;75(8):2027; author reply 2028.
2011: Vasilios G Athyros; Asterios Karagiannis; Konstantinos Tziomalos; Dimitri P Mikhailidis
Dyslipidaemia of obesity, metabolic syndrome and type 2 diabetes mellitus: the case for residual risk reduction after statin treatment.
The open cardiovascular medicine journal 2011;5():24-34.
2010: Vasilios G Athyros; Konstantinos Tziomalos; Thomas D Gossios; Theodora Griva; Panagiotis Anagnostis; Konstantinos Kargiotis; Efstathios D Pagourelias; Eleni Theocharidou; Asterios Karagiannis; Dimitri P Mikhailidis
Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis.
Lancet 2010;376(9756):1916-22.
2010: Vasilios G Athyros; Konstantinos Tziomalos; Asterios Karagiannis; Dimitri P Mikhailidis
To switch (statins) or not to switch? That is the question.
Expert opinion on pharmacotherapy 2010;11(18):2943-6.
2010: Theodoros Chimonas; Asterios Karagiannis; Vassilios G Athyros; Apostolos Achimastos; Moses Elisaf; Demosthenes B Panagiotakos
Blood pressure levels constitute the most important determinant of the metabolic syndrome in a Mediterranean population: a discrimination analysis.
Metabolic syndrome and related disorders 2010;8(6):523-9.
2010: Asterios Karagiannis; Konstantinos Tziomalos; Panagiotis Anagnostis; Thomas D Gossios; Matilda Florentin; Vasilios G Athyros; Dimitri P Mikhailidis
The effect of antihypertensive agents on insulin sensitivity, lipids and haemostasis.
Current vascular pharmacology 2010;8(6):792-803.
2010: Niki Katsiki; Dimitri P Mikhailidis; Vasilis G Athyros; Apostolos I Hatzitolios; Asterios Karagiannis; Maciej Banach
Are we getting to lipid targets in real life?
Archives of medical science : AMS 2010;6(5):639-41.
2010: Vasilios G Athyros; Konstantinos Tziomalos; Asterios Karagiannis; Dimitri P Mikhailidis
Statin-fibrate combination for mixed dyslipidaemia: a limited option?
Current medical research and opinion 2010;26(9):2137-40.
2010: Konstantinos Tziomalos; Vasilios G Athyros; Asterios Karagiannis; Dimitri P Mikhailidis
Management of statin-intolerant high-risk patients.
Current vascular pharmacology 2010;8(5):632-7.
2010: Panagiotis Anagnostis; Asterios Karagiannis; Konstantinos Tziomalos; Vasilios G Athyros; Marina Kita; Dimitri P Mikhailidis
Endocrine hypertension: diagnosis and management of a complex clinical entity.
Current vascular pharmacology 2010;8(5):646-60.
2010: Panagiotis Anagnostis; Vasilios G Athyros; Fotini Adamidou; Matilda Florentin; Asterios Karagiannis
Vitamin D and cardiovascular disease: a novel agent for reducing cardiovascular risk?
Current vascular pharmacology 2010;8(5):720-30.
2010: Vasilios G Athyros; Konstantinos Tziomalos; Asterios Karagiannis; Dimitri P Mikhailidis
Lipid-lowering agents and new onset diabetes mellitus.
Expert opinion on pharmacotherapy 2010;11(12):1965-70.
2010: Vasilios G Athyros; Konstantinos Tziomalos; Asterios Karagiannis; Dimitri P Mikhailidis
Atorvastatin: safety and tolerability.
Expert opinion on drug safety 2010;9(4):667-74.
2010: Konstantinos Tziomalos; Vasilios G Athyros; Asterios Karagiannis; Dimitri P Mikhailidis
The role of ankle brachial index and carotid intima-media thickness in vascular risk stratification.
Current opinion in cardiology 2010;25(4):394-8.
2010: Vasilios G Athyros; Konstantinos Tziomalos; Asterios Karagiannis; Anthony S Wierzbicki; Dimitri P Mikhailidis
Aggressive statin treatment, very low serum cholesterol levels and haemorrhagic stroke: is there an association?
Current opinion in cardiology 2010;25(4):406-10.
2010: Asterios Karagiannis; Konstantinos Tziomalos; Efstathios D Pagourelias; Thomas D Gossios; Vasilios G Athyros
Effect of antihypertensive drug-associated diabetes on cardiovascular risk.
Hellenic journal of cardiology : HJC = Hellēnikē kardiologikē epitheōrēsē 2010;51(3):195-9.
2010: Vasilios G Athyros; Asterios Karagiannis; Dimitri P Mikhailidis
Statins and heart failure.
Journal of the American College of Cardiology 2010;55(15):1644-5; author reply 1646.
2010: Vasilios G Athyros; Eydoxia K Mitsiou; Konstantinos Tziomalos; Asterios Karagiannis; Dimitri P Mikhailidis
Impact of managing atherogenic dyslipidemia on cardiovascular outcome across different stages of diabetic nephropathy.
Expert opinion on pharmacotherapy 2010;11(5):723-30.
2010: Vasilios G Athyros; Konstantinos Tziomalos; Matilda Florentin; Asterios Karagiannis; Dimitri P Mikhailidis
Statin loading in patients undergoing percutaneous coronary intervention for acute coronary syndromes: a new pleiotropic effect?
Current medical research and opinion 2010;26(4):839-42.
2010: E D Pagourelias; G Giannoglou; Evangelia Kouidi; Georgios K Efthimiadis; P Zorou; K Tziomalos; Asterios Karagiannis; Vasilios G Athyros; P Geleris; Dimitri P Mikhailidis
Brain natriuretic peptide and the athlete's heart: a pilot study.
International journal of clinical practice 2010;64(4):511-7.
2010: Vasilios G Athyros; Emmanuel S Ganotakis; Konstantinos Tziomalos; Athanasios A Papageorgiou; Panagiotis Anagnostis; Theodora Griva; Konstantinos Kargiotis; Eydoxia K Mitsiou; Asterios Karagiannis; Dimitri P Mikhailidis
Comparison of four definitions of the metabolic syndrome in a Greek (Mediterranean) population.
Current medical research and opinion 2010;26(3):713-9.
2010: Vasilios G Athyros; Konstantinos Tziomalos; Asterios Karagiannis; Dimitri P Mikhailidis
Preventing type 2 diabetes mellitus: room for residual risk reduction after lifestyle changes?
Current pharmaceutical design 2010;16(34):3939-847.
2010: Vasilios G Athyros; Eydoxia K Mitsiou; Konstantinos Tziomalos; Asterios Karagiannis; Dimitri P Mikhailidis
Concurrent blood pressure, glycemic and lipid control for the prevention of vascular complications of type II diabetes mellitus: a long overdue objective?
Current vascular pharmacology 2010;8(1):1-4.
2010: Vasilios G Athyros; Konstantinos Tziomalos; Asterios Karagiannis; Panagiotis Anagnostis; Dimitri P Mikhailidis
Should adipokines be considered in the choice of the treatment of obesity-related health problems?
Current drug targets 2010;11(1):122-35.
2009: Eydoxia K Mitsiou; Konstantinos Tziomalos; Panagiotis Anagnostis; Asterios Karagiannis; Vasilios G Athyros
Multifactorial intervention for the prevention of vascular complications of type 2 diabetes.
Hellenic journal of cardiology : HJC = Hellēnikē kardiologikē epitheōrēsē 2009;50(6):445-8.
2009: Vasilios G Athyros; A Hatzitolios; Asterios Karagiannis; Triandafillos P Didangelos; F Iliadis; S Dolgyras; T Vosnakidis; P Vasiliadis; I Malias; Konstantinos Tziomalos; M Samouilidou; Dimitri P Mikhailidis
Initiative for a new diabetes therapeutic approach in a Mediterranean country: the INDEED study.
Current medical research and opinion 2009;25(8):1931-40.
2009: Asterios Karagiannis; Konstantinos Tziomalos; Panagiotis Anagnostis; Thomas Gossios; Vasilios G Athyros
Atherosclerotic renal artery stenosis: medical therapy alone or in combination with revascularization?
Angiology 2009;60(4):397-402.
2009: Panagiotis Anagnostis; Vasilios G Athyros; Konstantinos Tziomalos; Asterios Karagiannis; Dimitri P Mikhailidis
Clinical review: The pathogenetic role of cortisol in the metabolic syndrome: a hypothesis.
The Journal of clinical endocrinology and metabolism 2009;94(8):2692-701.
2009: Panagiotis Anagnostis; Asterios Karagiannis; Konstantinos Tziomalos; Anna I Kakafika; Vasilios G Athyros; Dimitri P Mikhailidis
Adrenal incidentaloma: a diagnostic challenge.
Hormones (Athens, Greece) 2009;8(3):163-84.
2009: Vasilios G Athyros; Konstantinos Tziomalos; Asterios Karagiannis; Dimitri P Mikhailidis
Statins and cardiovascular events in patients with end-stage renal disease on hemodialysis. The AURORA results suggest the need for earlier intervention.
Current vascular pharmacology 2009;7(3):264-6.
2009: Konstantinos Tziomalos; Vasilios G Athyros; Asterios Karagiannis; Genovefa D Kolovou; Dimitri P Mikhailidis
Triglycerides and vascular risk: insights from epidemiological data and interventional studies.
Current drug targets 2009;10(4):320-7.
2009: Asterios Karagiannis; Vasilios G Athyros; Dimitri P Mikhailidis
A comparison of the aldosterone-blocking agents eplerenone and spironolactone.
Clinical cardiology 2009;32(4):230.
2009: Vasilios G Athyros; Asterios Karagiannis; A I Hatzitolios; K Paletas; C Savopoulos; G Giannoglou; Dimitri P Mikhailidis
Standardized arrangement for a guideline-driven treatment of the metabolic syndrome: the SAGE-METS study.
Current medical research and opinion 2009;25(4):971-80.
2009: Vasilios G Athyros; Konstantinos Tziomalos; Asterios Karagiannis; Dimitri P Mikhailidis
The JUPITER trial results boost the evidence for the use of hsCRP as a treatment target and as part of the assessment of vascular risk: time for new guidelines?
Hellenic journal of cardiology : HJC = Hellēnikē kardiologikē epitheōrēsē 2009;50(2):89-91.
2009: Efstathios D Pagourelias; Charalambos Koumaras; Anna I Kakafika; Konstantinos Tziomalos; Paraskevi G Zorou; Vasilios G Athyros; Asterios Karagiannis
Cardiorenal anemia syndrome: do erythropoietin and iron therapy have a place in the treatment of heart failure?
Angiology 2009;60(1):74-81.
2009: Konstantinos Tziomalos; Vasilios G Athyros; Asterios Karagiannis; Dimitri P Mikhailidis
Dyslipidemia as a risk factor for ischemic stroke.
Current topics in medicinal chemistry 2009;9(14):1291-7.
2009: Asterios Karagiannis; Apostolos Hatzitolios; Vasilios G Athyros; Kalliopi Deligianni; Charalambos Charalambous; Christos Papathanakis; Georgios Theodosiou; Theodoros Drakidis; Veronika Chatzikaloudi; Chysanthi Kamilali; Sotirios Matsiras; Athanasios Matziris; Christos Savopoulos; Maria Baltatzi; Jobst Rudolf; Konstantinos Tziomalos; Dimitri P Mikhailidis
Implementation of guidelines for the management of arterial hypertension. The impulsion study.
The open cardiovascular medicine journal 2009;3():26-34.
2009: Konstantinos Tziomalos; Anna I Kakafika; Vasilios G Athyros; Asterios Karagiannis; Dimitri P Mikhailidis
The role of statins for the primary and secondary prevention of coronary heart disease in women.
Current pharmaceutical design 2009;15(10):1054-62.
2009: Konstantinos Tziomalos; Vasilios G Athyros; Asterios Karagiannis; Dimitri P Mikhailidis
JUPITER: major implications for vascular risk assessment.
Current medical research and opinion 2009;25(1):133-7.
2009: Vasilios G Athyros; Anna I Kakafika; Konstantinos Tziomalos; Asterios Karagiannis; Dimitri P Mikhailidis
Pleiotropic effects of statins--clinical evidence.
Current pharmaceutical design 2009;15(5):479-89.
2009: Konstantinos Tziomalos; Vasilios G Athyros; Asterios Karagiannis; Dimitri P Mikhailidis
Anti-inflammatory effects of fibrates: an overview.
Current medicinal chemistry 2009;16(6):676-84.
2009: Vasilios G Athyros; Anna I Kakafika; Anthony S Wierzbicki; Asterios Karagiannis; Dimitri P Mikhailidis
Targeting triglycerides in secondary prevention: should we bother?
International journal of clinical practice 2009;63(1):15-8.
2008: Vasilios G Athyros; Konstantinos Tziomalos; Asterios Karagiannis; Dimitri P Mikhailidis
Preventing macrovascular complications of diabetes: where do we stand with glycemic control?
Expert opinion on investigational drugs 2008;17(12):1777-9.
2008: Konstantinos Tziomalos; Vasilios G Athyros; Asterios Karagiannis; Dimitri P Mikhailidis
Omega-3 fatty acids: how can they be used in secondary prevention?
Current atherosclerosis reports 2008;10(6):510-7.
2008: Asterios Karagiannis; Konstantinos Tziomalos; Anna I Kakafika; Vasilios G Athyros; Faidon Harsoulis; Dimitri P Mikhailidis
Medical treatment as an alternative to adrenalectomy in patients with aldosterone-producing adenomas.
Endocrine-related cancer 2008;15(3):693-700.
2008: Vasilios G Athyros; Anna I Kakafika; Asterios Karagiannis; Dimitri P Mikhailidis
Do we need to consider inflammatory markers when we treat atherosclerotic disease?
Atherosclerosis 2008;200(1):1-12.
2008: Konstantinos Tziomalos; Vasilios G Athyros; Asterios Karagiannis; Dimitri P Mikhailidis
Established and emerging vascular risk factors and the development of aortic stenosis: an opportunity for prevention?
Expert opinion on therapeutic targets 2008;12(7):809-20.
2008: Vasilios G Athyros; Anna I Kakafika; Konstantinos Tziomalos; Asterios Karagiannis; Dimitri P Mikhailidis
Antisense technology for the prevention or the treatment of cardiovascular disease: the next blockbuster?
Expert opinion on investigational drugs 2008;17(7):969-72.
2008: Anna I Kakafika; Vasilios G Athyros; Konstantinos Tziomalos; Asterios Karagiannis; Dimitri P Mikhailidis
Primary and secondary coronary heart disease prevention using statins: is targeting Adam or Eve equally effective?
Expert opinion on pharmacotherapy 2008;9(9):1437-40.
2008: Vasilios G Athyros; Anna I Kakafika; Athanasios A Papageorgiou; Kosmas I Paraskevas; Konstantinos Tziomalos; Panagiotis Anagnostis; Efstathios Pagourelias; Charalambos Koumaras; Asterios Karagiannis; Dimitri P Mikhailidis
Effects of statin treatment in men and women with stable coronary heart disease: a subgroup analysis of the GREACE Study.
Current medical research and opinion 2008;24(6):1593-9.
2008: Vasilios G Athyros; Anna I Kakafika; Konstantinos Tziomalos; Athanassios A Papageorgiou; Asterios Karagiannis
Statins for the prevention of first or recurrent stroke.
Current vascular pharmacology 2008;6(2):124-33.
2008: Asterios Karagiannis; Dimitri P Mikhailidis; Konstantinos Tziomalos; Anna I Kakafika; Vasilios G Athyros
Has the time come for a new definition of microalbuminuria?
Current vascular pharmacology 2008;6(2):81-3.
2008: Vasilios G Athyros; Anna Kakafika; Konstantinos Tziomalos; Asterios Karagiannis; Dimitri P Mikhailidis
Cholesteryl ester transfer protein inhibition and HDL increase: has the dream ended?
Expert opinion on investigational drugs 2008;17(4):445-9.
2008: Asterios Karagiannis; Konstantinos Tziomalos; Athanasios Papageorgiou; Anna I Kakafika; Efstathios D Pagourelias; Panagiotis Anagnostis; Vasilios G Athyros; Dimitri P Mikhailidis
Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism.
Expert opinion on pharmacotherapy 2008;9(4):509-15.
2008: Christos Sambanis; Konstantinos Tziomalos; Evangelia Kountana; Nikitas Kakavas; Ioanna Zografou; Aikaterini Balaska; Georgios Koulas; Asterios Karagiannis; Chrysanthos Zamboulis
Effect of pioglitazone on heart function and N-terminal pro-brain natriuretic peptide levels of patients with type 2 diabetes.
Acta diabetologica 2008;45(1):23-30.
2008: Vasilios G Athyros; Konstantinos Tziomalos; Anna I Kakafika; Haralambos Koumaras; Asterios Karagiannis; Dimitri P Mikhailidis
Effectiveness of ezetimibe alone or in combination with twice a week Atorvastatin (10 mg) for statin intolerant high-risk patients.
The American journal of cardiology 2008;101(4):483-5.
2008: Vasilios G Athyros; Anna I Kakafika; Konstantinos Tziomalos; Asterios Karagiannis; Dimitri P Mikhailidis
CORONA, statins, and heart failure: who lost the crown?
Angiology 2008;59(1):5-8.
2008: Anna I Kakafika; Vasilios G Athyros; Konstantinos Tziomalos; Asterios Karagiannis; Dimitri P Mikhailidis
High density lipoprotein cholesterol and statin trials.
Current medicinal chemistry 2008;15(22):2265-70.
2008: Panagiotis Anagnostis; Maria Stangou; Maria Leontsini; Vasilios G Athyros; Asterios Karagiannis
Unusual manifestation of diarrhea-associated haemolytic uraemic syndrome in an adult.
Renal failure 2008;30(3):331-4.
2007: Vasilios G Athyros; Evagelos N Liberopoulos; Dimitri P Mikhailidis; Athanasios A Papageorgiou; Emmanuel S Ganotakis; Konstantinos Tziomalos; Anna I Kakafika; Asterios Karagiannis; Stylianos Lambropoulos; Moses Elisaf
Association of drinking pattern and alcohol beverage type with the prevalence of metabolic syndrome, diabetes, coronary heart disease, stroke, and peripheral arterial disease in a Mediterranean cohort.
Angiology 2007;58(6):689-97.
2007: Asterios Karagiannis; Dimitri P Mikhailidis; Vasilios G Athyros; Faidon Harsoulis
Pheochromocytoma: an update on genetics and management.
Endocrine-related cancer 2007;14(4):935-56.
2007: Vasilios G Athyros; Anna I Kakafika; Athanasios A Papageorgiou; Konstantinos Tziomalos; Athanasios Skaperdas; Efstathios Pagourelias; Athina Pirpasopoulou; Asterios Karagiannis; Dimitri P Mikhailidis
Atorvastatin decreases triacylglycerol-associated risk of vascular events in coronary heart disease patients.
Lipids 2007;42(11):999-1009.
2007: Vasilios G Athyros; Konstantinos Tziomalos; Dimitri P Mikhailidis; Efstathios D Pagourelias; Anna I Kakafika; Athanasios Skaperdas; Apostolos Hatzitolios; Asterios Karagiannis
Do we need a statin-nicotinic acid-aspirin mini-polypill to treat combined hyperlipidaemia?
Expert opinion on pharmacotherapy 2007;8(14):2267-77.
2007: Konstantinos Tziomalos; Vasilios G Athyros; Asterios Karagiannis; Dimitri P Mikhailidis
Endothelial function, arterial stiffness and lipid lowering drugs.
Expert opinion on therapeutic targets 2007;11(9):1143-60.
2007: Kosmas I Paraskevas; Vasilios G Athyros; Despina D Briana; Anna I Kakafika; Asterios Karagiannis; Dimitri P Mikhailidis
Statins exert multiple beneficial effects on patients undergoing percutaneous revascularization procedures.
Current drug targets 2007;8(8):942-51.
2007: Anna I Kakafika; Dimitri P Mikhailidis; Anthony S Wierzbicki; Asterios Karagiannis; Vasilios G Athyros
PCI and stable coronary heart disease--COURAGE to change our minds?
Current vascular pharmacology 2007;5(3):173-4.
2007: Asterios Karagiannis; Dimitri P Mikhailidis; Konstantinos Tziomalos; Maria Sileli; Savvas Savvatianos; Anna I Kakafika; Thomas Gossios; Napoleon Krikis; Irene Moschou; Michael Xochellis; Vasilios G Athyros
Serum uric acid as an independent predictor of early death after acute stroke.
Circulation journal : official journal of the Japanese Circulation Society 2007;71(7):1120-7.
2007: Vasilios G Athyros; Anna I Kakafika; Asterios Karagiannis; Dimitri P Mikhailidis
Statins and regression of coronary atherosclerosis.
JAMA : the journal of the American Medical Association 2007;297(20):2197; author reply 2197.
2007: Konstantinos Tziomalos; Matilda Florentin; Napoleon Krikis; Vassilios Perifanis; Asterios Karagiannis; Faidon Harsoulis
Persistent effect of zoledronic acid in Paget's disease.
Clinical and experimental rheumatology 2007;25(3):464-6.
2007: Asterios Karagiannis; Konstantinos Tziomalos; Vasilios G Athyros
Is angioedema a class adverse effect of the angiotensin-converting enzyme inhibitors?
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2007;98(5):502.
2007: Anna I Kakafika; Dimitri P Mikhailidis; Asterios Karagiannis; Vasilios G Athyros
The role of endocannabinoid system blockade in the treatment of the metabolic syndrome.
Journal of clinical pharmacology 2007;47(5):642-52.
2007: Vasilios G Athyros; Emmanuel S Ganotakis; Moses S Elisaf; Evagelos N Liberopoulos; Ioannis A Goudevenos; Asterios Karagiannis
Prevalence of vascular disease in metabolic syndrome using three proposed definitions.
International journal of cardiology 2007;117(2):204-10.
2007: Vasilios G Athyros; Dimitri P Mikhailidis; Anna I Kakafika; Konstantinos Tziomalos; Asterios Karagiannis
Angiotensin II reactivation and aldosterone escape phenomena in renin-angiotensin-aldosterone system blockade: is oral renin inhibition the solution?
Expert opinion on pharmacotherapy 2007;8(5):529-35.
2007: Vasilios G Athyros; Dimitri P Mikhailidis; Anna I Kakafika; Asterios Karagiannis; Apostolos Hatzitolios; Konstantinos Tziomalos; Emmanuel S Ganotakis; Evagelos N Liberopoulos; Moses Elisaf
Identifying and attaining LDL-C goals: mission accomplished? Next target: new therapeutic options to raise HDL-C levels.
Current drug targets 2007;8(3):483-8.
2007: V G Athyros; Asterios Karagiannis; Evagelos N Liberopoulos; M Elisaf; D P Mikhailidis
Statin treatment may be beneficial to both the kidneys and the heart.
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 2007;27(2):215-6.
2007: Vasilios G Athyros; Asterios Karagiannis; Anna I Kakafika; Moses Elisaf; Dimitri P Mikhailidis
Statins and renal function. Is the compound and dose making a difference?
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007;22(3):963-4; author reply 964.
2007: Asterios Karagiannis; Dimitri P Mikhailidis; Vasilios G Athyros; Anna I Kakafika; Konstantinos Tziomalos; Evagelos N Liberopoulos; Matilda Florentin; Moses Elisaf
The role of renin-angiotensin system inhibition in the treatment of hypertension in metabolic syndrome: are all the angiotensin receptor blockers equal?
Expert opinion on therapeutic targets 2007;11(2):191-205.
2007: Vasilios G Athyros; Anna I Kakafika; Athanasios A Papageorgiou; Efstathios D Pagourelias; Savvas D Savvatianos; Moses Elisaf; Asterios Karagiannis; Konstantinos Tziomalos; Dimitri P Mikhailidis
Statin-Induced Increase in HDL-C and Renal Function in Coronary Heart Disease Patients.
The open cardiovascular medicine journal 2007;1():8-14.
2007: Athina Pyrpasopoulou; V G Athyros; Asterios Karagiannis; F Chrysomallis; Chrysanthos Zamboulis
Intravenous immunoglobulins: a valuable asset in the treatment of a case of septic febrile ulceronecrotic Mucha-Habermann disease.
Dermatology (Basel, Switzerland) 2007;215(2):164-5.
2007: Asterios Karagiannis; Dimitri P Mikhailidis; Anna I Kakafika; Konstantinos Tziomalos; Vasilios G Athyros
Atenolol: differences in mode of action compared with other antihypertensives. An opportunity to identify features that influence outcome?
Current pharmaceutical design 2007;13(2):229-39.
2007: Asterios Karagiannis; Konstantinos Tziomalos; Anna I Kakafika; Matilda Florentin; Vasilios G Athyros
Eplerenone relieves spironolactone-induced painful gynaecomastia in a patient with primary aldosteronism.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007;22(1):293.
2007: Vasilios G Athyros; Dimitri P Mikhailidis; Evagelos N Liberopoulos; Anna I Kakafika; Asterios Karagiannis; Athanasios A Papageorgiou; Konstantinos Tziomalos; Emmanuel S Ganotakis; Moses Elisaf
Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: a subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) Study.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007;22(1):118-27.
2006: Asterios Karagiannis; Lemonia Mathiopoulou; Konstantinos Tziomalos; Konstantinos Kontotasios; Athanasios Skaperdas; Matilda Florentin; Ioannis K Amplianitis; Vasilios G Athyros
Dry cough as first manifestation of giant-cell arteritis.
Journal of the American Geriatrics Society 2006;54(12):1957-8.
2006: Timoleon Vyzantiadis; Asterios Karagiannis; Stella Douma; Phaedon Harsoulis; Athanassios Vyzantiadis; Chrysanthos Zamboulis
Vascular endothelial growth factor and nitric oxide serum levels in arterial hypertension.
Clinical and experimental hypertension (New York, N.Y. : 1993) 2006;28(7):603-9.
2006: Asterios Karagiannis; Vasilios G Athyros; Athanasios Papageorgiou; Konstantinos Tziomalos; Moses Elisaf
Should atenolol still be recommended as first-line therapy for primary hypertension?
Hellenic journal of cardiology : HJC = Hellēnikē kardiologikē epitheōrēsē 2006;47(5):298-307.
2006: Anna I Kakafika; Evagelos N Liberopoulos; Asterios Karagiannis; Vasilios G Athyros; Dimitri P Mikhailidis
Dyslipidaemia, hypercoagulability and the metabolic syndrome.
Current vascular pharmacology 2006;4(3):175-83.
2006: Vasilios G Athyros; Dimitri P Mikhailidis; Triandafillos P Didangelos; Olga Giouleme; Evagelos N Liberopoulos; Asterios Karagiannis; Anna I Kakafika; Konstantinos Tziomalos; Andrew K Burroughs; Moses S Elisaf
Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study.
Current medical research and opinion 2006;22(5):873-83.
2006: Asterios Karagiannis; Athina Pyrpasopoulou; Konstantinos Tziomalos; Matilda Florentin; Vasilios G Athyros
Angioedema may not be a class side-effect of the angiotensin-converting-enzyme inhibitors.
QJM : monthly journal of the Association of Physicians 2006;99(3):197-8.
2005: Asterios Karagiannis; Konstantinos Tziomalos; Konstantina Dona; Athina Pyrpasopoulou; Nikoleta Kartali; Vasilios G Athyros; Chrysanthos Zamboulis
Bilateral renal artery stenosis and primary aldosteronism in a diabetic patient.
QJM : monthly journal of the Association of Physicians 2005;98(12):913-5.
2005: Asterios Karagiannis; Konstantinos Tziomalos; Napoleon Krikis; Georgios Sfikas; Konstantina Dona; Chrysanthos Zamboulis
The unilateral measurement of blood pressure may mask the diagnosis or delay the effective treatment of hypertension.
Angiology 2005;56(5):565-9.
2005: Vasilios G Athyros; Dimitri P Mikhailidis; Athanasios A Papageorgiou; Triandafillos P Didangelos; Athanasia Peletidou; Drosia Kleta; Asterios Karagiannis; Anna I Kakafika; Konstantinos Tziomalos; Moses Elisaf
Targeting vascular risk in patients with metabolic syndrome but without diabetes.
Metabolism: clinical and experimental 2005;54(8):1065-74.
2005: Asterios Karagiannis; Ioannis Tsorlalis; Anna I Kakafika; Panagiotis Pateinakis; Vassilios Perifanis; Faidon Harsoulis
Acute renal failure due to tumor lysis syndrome in a patient with non-Hodgkin's lymphoma.
Annals of hematology 2005;84(5):343-6.
2005: Asterios Karagiannis; Faidon Harsoulis
Gonadal dysfunction in systemic diseases.
European journal of endocrinology / European Federation of Endocrine Societies 2005;152(4):501-13.
2005: Napoleon Krikis; K Tziomalos; Vassilios Perifanis; Sofia Vakalopoulou; Asterios Karagiannis; Vassilia Garipidou; Faidon Harsoulis
Treatment of recurrent gastrointestinal haemorrhage in a patient with von Willebrand's disease with octreotide LAR and propranolol.
Gut 2005;54(1):171-2.
2004: Asterios Karagiannis; Konstantinos Tziomalos; Chrysanthos Zamboulis
Plasma B-type natriuretic peptide is related to left ventricular mass in hypertensive patients.
European heart journal 2004;25(21):1967.
2004: Asterios Karagiannis; Konstantinos Tziomalos; Anna I Kakafika; Faidon Harsoulis; Chrysanthos Zamboulis
Paralysis as first manifestation of primary aldosteronism.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2004;19(9):2418-9.
2004: K Tziomalos; Napoleon Krikis; Asterios Karagiannis; Vassilios Perifanis; Despoina Rizopoulou; V Georgopoulou; Faidon Harsoulis
Treatment of idiopathic retroperitoneal fibrosis with combined administration of corticosteroids and tamoxifen.
Clinical nephrology 2004;62(1):74-6.
2004: Asterios Karagiannis; Katerina Balaska; Konstantinos Tziomalos; Thomas Gerasimidis; Dimitrios Karamanos; Athanasios Papayeoryiou; Chrysanthos Zamboulis
Lack of an association between angiotensin converting enzyme gene polymorphism and peripheral arterial occlusive disease.
Vascular medicine (London, England) 2004;9(3):189-92.
2004: Asterios Karagiannis; Konstantinos Tziomalos; Kalliopi Patsiaoura; Nikolaos Nikolaidis; Olga Giouleme; Nikolaos Mavroudis; Nikolaos Evgenidis; Chrysanthos Zamboulis
Focal nodular hyperplasia of the liver in a patient with primary aldosteronism.
Journal of gastroenterology and hepatology 2004;19(4):480-1.
2004: Napoleon Krikis; Konstantinos Tziomalos; Vassilios Perifanis; Sofia Vakalopoulou; Asterios Karagiannis; Vasilia Garypidou; Faidon Harsoulis
Treatment of recurrent gastrointestinal haemorrhage in a patient with von Willebrand's disease with administration of octreotide LAR and propranolol.
Hormones (Athens, Greece) 2004;3(1):65-7.
2004: Asterios Karagiannis; Katerina Balaska; Konstantinos Tziomalos; Laokratia Tokalaki-Nikolaidou; Athanasios Papayeoryiou; Chrysanthos Zamboulis
Lack of an association between angiotensin-converting enzyme gene insertion/deletion polymorphism and ischaemic stroke.
European neurology 2004;51(3):148-52.